CymaBay Therapeutics' IPO

CymaBay Therapeutics raised a round of funding on July 28, 2014. Investors include Public.

CymaBay Therapeutics, formerly Metabolex, is a privately-held biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, w…

Articles about CymaBay Therapeutics' IPO: